{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:12:44Z","timestamp":1778649164315,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1092642"],"award-info":[{"award-number":["1092642"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["NP202"],"award-info":[{"award-number":["NP202"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.lfs.2021.120220","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T01:55:43Z","timestamp":1639101343000},"page":"120220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["NP202 treatment improves left ventricular systolic function and attenuates pathological remodelling following chronic myocardial infarction"],"prefix":"10.1016","volume":"289","author":[{"given":"Andrew R.","family":"Kompa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fay L.","family":"Khong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda J.","family":"Edgley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen L.","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"McLachlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.120220_bb0005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1027351808326","article-title":"Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapy","volume":"17","author":"Remme","year":"2003","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.lfs.2021.120220_bb0010","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.abb.2003.08.037","article-title":"Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms","volume":"420","author":"Marczin","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.lfs.2021.120220_bb0015","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2174\/1389450116666151001112020","article-title":"New pharmacological approaches to the prevention of myocardial ischemia- reperfusion injury","volume":"18","author":"Chin","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.lfs.2021.120220_bb0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.yjmcc.2008.12.003","article-title":"Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury","volume":"46","author":"Akhlaghi","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2021.120220_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1039\/c0md00240b","article-title":"Water soluble flavonol prodrugs that protect against ischaemia-reperfusion injury in rat hindlimb and sheep heart","volume":"2","author":"Williams","year":"2011","journal-title":"Med Chem Comm"},{"key":"10.1016\/j.lfs.2021.120220_bb0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/BJ20121538","article-title":"Cardioprotective 3',4'-dihydroxyflavonol attenuation of JNK and p38(MAPK) signalling involves CaMKII inhibition","volume":"456","author":"Lim","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2021.120220_bb0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2015.03.054","article-title":"Evidence that the MEK\/ERK but not the PI3K\/Akt pathway is required for protection from myocardial ischemia-reperfusion injury by 3',4'-dihydroxyflavonol","volume":"758","author":"Thomas","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120220_bb0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2011.02.041","article-title":"Cardioprotection from ischaemia-reperfusion injury by a novel flavonol that reduces activation of p38 MAPK","volume":"658","author":"Thomas","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120220_bb0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjp.0705815","article-title":"3',4'-dihydroxyflavonol reduces infarct size and injury associated with myocardial ischaemia and reperfusion in sheep","volume":"142","author":"Wang","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120220_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2009.10.001","article-title":"3',4'-dihydroxyflavonol improves post-ischaemic coronary endothelial function following 7days reperfusion in sheep","volume":"624","author":"Wang","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120220_bb0055","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.freeradbiomed.2011.07.003","article-title":"Antioxidant activity contributes to flavonol cardioprotection during reperfusion of rat hearts","volume":"51","author":"Qin","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120220_bb0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ijcard.2017.11.101","article-title":"Protection against reperfusion injury by 3',4'-dihydroxyflavonol in rat isolated hearts involves inhibition of phospholamban and JNK2","volume":"254","author":"Chin","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2021.120220_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022777","article-title":"3',4'-dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 rats","volume":"6","author":"Khong","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.120220_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020813","article-title":"3',4'-dihydroxyflavonol reduces superoxide and improves nitric oxide function in diabetic rat mesenteric arteries","volume":"6","author":"Leo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.120220_bb0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.phrs.2014.01.004","article-title":"The cardioprotectant 3',4'-dihydroxyflavonol inhibits opening of the mitochondrial permeability transition pore after myocardial ischemia and reperfusion in rats","volume":"81","author":"Woodman","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2021.120220_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083687","article-title":"The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction","volume":"8","author":"Lekawanvijit","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.120220_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/CIRCHEARTFAILURE.108.765750","article-title":"Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy","volume":"2","author":"Connelly","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.lfs.2021.120220_bb0090","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on standards, subcommittee on quantitation of two-dimensional echocardiograms","volume":"2","author":"Schiller","year":"1989","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.lfs.2021.120220_bb0095","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijcard.2011.12.062","article-title":"Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction","volume":"167","author":"Kompa","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2021.120220_bb0100","first-page":"61","article-title":"Dihydroxyflavonol reduces post-infarction left ventricular remodeling by preventing myocyte apoptosis in the non-infarcted zone in goats","volume":"122","author":"Wang","year":"2009","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.lfs.2021.120220_bb0105","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.15252\/emmm.201403848","article-title":"CaM kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia\/reperfusion injury","volume":"6","author":"Weinreuter","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.lfs.2021.120220_bb0110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nm1215","article-title":"Calmodulin kinase II inhibition protects against structural heart disease","volume":"11","author":"Zhang","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2021.120220_bb0115","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/01.RES.0000069686.31472.C5","article-title":"The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure","volume":"92","author":"Zhang","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.lfs.2021.120220_bb0120","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1476-5381.2009.00199.x","article-title":"3',4'-dihydroxyflavonol down-regulates monocyte chemoattractant protein-1 in smooth muscle: role of focal adhesion kinase and PDGF receptor signalling","volume":"157","author":"Jiang","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120220_bb0125","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/cvr\/cvn333","article-title":"Myocardial repair\/remodelling following infarction: roles of local factors","volume":"81","author":"Sun","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2021.120220_bb0130","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/j.1755-5922.2010.00228.x","article-title":"Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-beta","volume":"30","author":"Edgley","year":"2012","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.lfs.2021.120220_bb0135","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.fct.2013.10.045","article-title":"Astilbin protects diabetic rat heart against ischemia-reperfusion injury via blockade of HMGB1-dependent NF-kappaB signaling pathway","volume":"63","author":"Diao","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.lfs.2021.120220_bb0140","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","article-title":"Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration","volume":"365","author":"Talman","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.lfs.2021.120220_bb0145","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbamcr.2012.08.023","article-title":"Fibroblasts in post-infarction inflammation and cardiac repair","volume":"1833","author":"Chen","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2021.120220_bb0150","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/FJC.0b013e3182116e39","article-title":"Fibroblasts and myofibroblasts: what are we talking about?","volume":"57","author":"Baum","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120220_bb0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0008-6363(00)00158-9","article-title":"Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb)","volume":"48","author":"Frangogiannis","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2021.120220_bb0160","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.jnutbio.2011.10.004","article-title":"Curcumin reduces the cardiac ischemia-reperfusion injury: involvement of the toll-like receptor 2 in cardiomyocytes","volume":"23","author":"Kim","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.lfs.2021.120220_bb0165","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/jmcb\/mjx046","article-title":"Myeloid adrenergic signaling via CaMKII forms a feedforward loop of catecholamine biosynthesis","volume":"9","author":"Luo","year":"2017","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2021.120220_bb0170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10753-016-0462-8","article-title":"Troxerutin preconditioning and ischemic postconditioning modulate inflammatory response after myocardial Ischemia\/Reperfusion injury in rat model","volume":"40","author":"Badalzadeh","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.lfs.2021.120220_bb0175","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.gene.2014.04.043","article-title":"Heart protective effects and mechanism of quercetin preconditioning on anti-myocardial ischemia reperfusion (IR) injuries in rats","volume":"545","author":"Liu","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.lfs.2021.120220_bb0180","doi-asserted-by":"crossref","first-page":"7580731","DOI":"10.1155\/2016\/7580731","article-title":"Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury","volume":"2016","author":"Suchal","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2021.120220_bb0185","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3109\/09537104.2012.749396","article-title":"Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin","volume":"24","author":"Mosawy","year":"2013","journal-title":"Platelets"},{"key":"10.1016\/j.lfs.2021.120220_bb0190","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3389\/fphar.2019.01081","article-title":"DiOHF protects against doxorubicin-induced cardiotoxicity through ERK1 signaling pathway","volume":"10","author":"Chang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120220_bb0195","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1038\/s41467-020-18165-6","article-title":"Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy","volume":"11","author":"Luczak","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2021.120220_bb0200","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.freeradbiomed.2019.11.012","article-title":"Inhibition of CaMKII in mitochondria preserves endothelial barrier function after irradiation","volume":"146","author":"Roy","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120220_bb0205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2017.11.024","article-title":"Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction","volume":"71","author":"Thackeray","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2021.120220_bb0210","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrg3244","article-title":"Studying and modelling dynamic biological processes using time-series gene expression data","volume":"13","author":"Bar-Joseph","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.lfs.2021.120220_bb0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrm1838","article-title":"Cell-signalling dynamics in time and space","volume":"7","author":"Kholodenko","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521012078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521012078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:45:15Z","timestamp":1778647515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521012078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":43,"alternative-id":["S0024320521012078"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120220","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NP202 treatment improves left ventricular systolic function and attenuates pathological remodelling following chronic myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120220"}}